167 related articles for article (PubMed ID: 20369733)
1. [The role of CR1 complement receptor in pathology].
Rochowiak A; Niemir ZI
Pol Merkur Lekarski; 2010 Jan; 28(163):84-8. PubMed ID: 20369733
[TBL] [Abstract][Full Text] [Related]
2. [The structure and role of CR1 complement receptor in physiology].
Rochowiak A; Niemir ZI
Pol Merkur Lekarski; 2010 Jan; 28(163):79-83. PubMed ID: 20369732
[TBL] [Abstract][Full Text] [Related]
3. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
4. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
[TBL] [Abstract][Full Text] [Related]
5. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.
Yoon SH; Fearon DT
J Immunol; 1985 May; 134(5):3332-8. PubMed ID: 3156931
[TBL] [Abstract][Full Text] [Related]
7. Association of complement receptor 1 (CR1, CD35, C3b/C4b receptor) density polymorphism with glomerulonephritis in Indian subjects.
Katyal M; Tiwari SC; Kumar A; Dinda AK; Arora V; Kumar R; Das N
Mol Immunol; 2004 Apr; 40(18):1325-32. PubMed ID: 15072851
[TBL] [Abstract][Full Text] [Related]
8. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
[TBL] [Abstract][Full Text] [Related]
9. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited.
Walport MJ; Ross GD; Mackworth-Young C; Watson JV; Hogg N; Lachmann PJ
Clin Exp Immunol; 1985 Mar; 59(3):547-54. PubMed ID: 3987091
[TBL] [Abstract][Full Text] [Related]
10. The human C3b receptor (CR1).
Weiss L; Fischer E; Haeffner-Cavaillon N; Jouvin MH; Appay MD; Bariety J; Kazatchkine M
Adv Nephrol Necker Hosp; 1989; 18():249-69. PubMed ID: 2522267
[TBL] [Abstract][Full Text] [Related]
11. Immune complex clearance by complement receptor type 1 in SLE.
Kavai M
Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
[TBL] [Abstract][Full Text] [Related]
12. Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage.
Danielsson C; Pascual M; French L; Steiger G; Schifferli JA
Eur J Immunol; 1994 Nov; 24(11):2725-31. PubMed ID: 7957565
[TBL] [Abstract][Full Text] [Related]
13. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor.
Subramanian VB; Clemenza L; Krych M; Atkinson JP
J Immunol; 1996 Aug; 157(3):1242-7. PubMed ID: 8757632
[TBL] [Abstract][Full Text] [Related]
14. Complement receptor 1 (CD35) on human reticulocytes: normal expression in systemic lupus erythematosus and HIV-infected patients.
Lach-Trifilieff E; Marfurt J; Schwarz S; Sadallah S; Schifferli JA
J Immunol; 1999 Jun; 162(12):7549-54. PubMed ID: 10358211
[TBL] [Abstract][Full Text] [Related]
15. Identification of complement receptor type 1-related proteins on primate erythrocytes.
Nickells MW; Subramanian VB; Clemenza L; Atkinson JP
J Immunol; 1995 Mar; 154(6):2829-37. PubMed ID: 7876553
[TBL] [Abstract][Full Text] [Related]
16. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM
J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655
[TBL] [Abstract][Full Text] [Related]
17. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
Medof ME; Nussenzweig V
J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387
[TBL] [Abstract][Full Text] [Related]
18. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
19. Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney.
Java A; Liszewski MK; Hourcade DE; Zhang F; Atkinson JP
Mol Immunol; 2015 Oct; 67(2 Pt B):584-95. PubMed ID: 26260209
[TBL] [Abstract][Full Text] [Related]
20. A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.
Scesney SM; Makrides SC; Gosselin ML; Ford PJ; Andrews BM; Hayman EG; Marsh HC
Eur J Immunol; 1996 Aug; 26(8):1729-35. PubMed ID: 8765013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
